Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, Wolfgang Hoeltl, Fernando Calais Da Silva, Philip H. Powell, Stephen Prescott, Ziya Kirkali, Cees van de Beek, Thierry Gorlia, Theo M. de Reijke

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)766-773
JournalEuropean Urology
Volume57
Issue number5
DOIs
Publication statusPublished - May 2010

Keywords

  • Bacillus Calmette-Guerin
  • Epirubicin
  • Instillation therapy
  • Isoniazid
  • Non-muscle-invasive bladder cancer
  • Randomized clinical trial
  • Urothelial carcinoma of the bladder

Cite this